Hydrazine hydrate (1:1) → O-(1-(3-(trifluoromethyl)phenylsulfonyl)piperidin-4-yl)hydroxylamine

HRID 1895904Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1895904
O.NN.[F:4][C:5]([F:34])([F:33])[C:6]1[CH:7]=[C:8]([S:12]([N:15]2[CH2:20][CH2:19][CH:18]([O:21][N:22]3C(=O)C4C(=CC=CC=4)C3=O)[CH2:17][CH2:16]2)(=[O:14])=[O:13])[CH:9]=[CH:10][CH:11]=1>C(O)C>[F:34][C:5]([F:4])([F:33])[C:6]1[CH:7]=[C:8]([S:12]([N:15]2[CH2:16][CH2:17][CH:18]([O:21][NH2:22])[CH2:19][CH2:20]2)(=[O:14])=[O:13])[CH:9]=[CH:10][CH:11]=1

Komponenten

4

Versuchsvorschrift

Hydrazine monohydrate (250 mg, 4.24 mmol) was added to a solution of 2-(1-(3-(trifluoromethyl)phenylsulfonyl)piperidin-4-yloxy)isoindoline-1,3-dione (1.02 g, 2.24 mmol) in ethanol (10 ml) and stirred at room temperature for 30 minutes. The resulting solid was filtered off and concentrated in vacuo. The residue was triturated with diethyl ether (30 ml), and the resulting solid was filtered off again and concentrated in vacuo to give O-(1-(3-(trifluoromethyl)phenylsulfonyl)piperidin-4-yl)hydroxylamine (720 mg, 94%) as a white solid: LCMS: 343 [M+1]+.

Aufarbeitung

  1. filtrationThe resulting solid was filtered off
  2. concentrationconcentrated in vacuo
  3. customThe residue was triturated with diethyl ether (30 ml)
  4. filtrationthe resulting solid was filtered off again
  5. concentrationconcentrated in vacuo

Quellen und Nachweise

ORD-Eintrag
ord-32d0a415837849fa861e8ad8bd22954a
Quelldatensatz
uspto-grants-2013_08
Patentnummer
US08518934B2

Notizen zur Reaktion

Wird geladen…